Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Harris

Showing results (111-120 of 200) with videos related to

Pageof 20
Sort By:
Plos One|April 23, 2016
Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing EnterobacteriaceaeTat Ming Ng, Wendy X Khong, Patrick N A Harris, et al.
Laboratory Medicine|April 23, 2022
Multiplex Microsphere PCR (mmPCR) Allows Simultaneous Gram Typing, Detection of Fungal DNA, and Antibiotic Resistance GenesDaniel J Browne, Fang Liang, Kate H Gartlan, et al.
Trials|December 8, 2021
Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trialHugh Wright, Patrick N A Harris, Mark D Chatfield, et al.
Jac-Antimicrobial Resistance|October 5, 2022
Determining the <i>in vitro</i> susceptibility of tebipenem, an oral carbapenem, against third-generation cephalosporin-resistant <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> isolated from bloodstream infectionsAma Ranasinghe, Andrew Henderson, Kyra Cottrell, et al.
Journal of Virological Methods|October 1, 2023
Evaluation of Illumina® COVIDSeq™ as a tool for Omicron SARS-CoV-2 characterisationKym Lowry, Michelle J Bauer, Cameron Buckley, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 10, 2023
Evolving insights into the epidemiology of Moraxella species bloodstream infection from two decades of surveillance in Queensland, AustraliaJessica Schults, Felicity Edwards, Karina Charles, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2021
Molecular Epidemiology of Third-Generation-Cephalosporin-Resistant <i>Enterobacteriaceae</i> in Southeast Queensland, AustraliaA G Stewart, E P Price, K Schabacker, et al.
Emerging Infectious Diseases|January 6, 2026
Metatranscriptomic Identification of Trubanaman Virus Sequences in Patient with Encephalitis, AustraliaKrispin Hajkowicz, John Woodford, Elango Subramonia Pillai, et al.
International Journal of Environmental Research and Public Health|January 24, 2020
Bacterial Profile, Multi-Drug Resistance and Seasonality Following Lower Limb Orthopaedic Surgery in Tropical and Subtropical Australian Hospitals: An Epidemiological Cohort StudyMark L Vickers, Emma L Ballard, Patrick N A Harris, et al.
Molecular Microbiology|February 10, 2021
Characterization of DtrJ as an IncC plasmid conjugative DNA transfer componentSteven J Hancock, Minh-Duy Phan, Leah W Roberts, et al.
Pageof 20

Showing results (111-120 of 200) with videos related to

Sort By:
Pageof 20
Plos One|April 23, 2016
Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing EnterobacteriaceaeTat Ming Ng, Wendy X Khong, Patrick N A Harris, et al.
Laboratory Medicine|April 23, 2022
Multiplex Microsphere PCR (mmPCR) Allows Simultaneous Gram Typing, Detection of Fungal DNA, and Antibiotic Resistance GenesDaniel J Browne, Fang Liang, Kate H Gartlan, et al.
Trials|December 8, 2021
Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trialHugh Wright, Patrick N A Harris, Mark D Chatfield, et al.
Jac-Antimicrobial Resistance|October 5, 2022
Determining the <i>in vitro</i> susceptibility of tebipenem, an oral carbapenem, against third-generation cephalosporin-resistant <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> isolated from bloodstream infectionsAma Ranasinghe, Andrew Henderson, Kyra Cottrell, et al.
Journal of Virological Methods|October 1, 2023
Evaluation of Illumina® COVIDSeq™ as a tool for Omicron SARS-CoV-2 characterisationKym Lowry, Michelle J Bauer, Cameron Buckley, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 10, 2023
Evolving insights into the epidemiology of Moraxella species bloodstream infection from two decades of surveillance in Queensland, AustraliaJessica Schults, Felicity Edwards, Karina Charles, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2021
Molecular Epidemiology of Third-Generation-Cephalosporin-Resistant <i>Enterobacteriaceae</i> in Southeast Queensland, AustraliaA G Stewart, E P Price, K Schabacker, et al.
Emerging Infectious Diseases|January 6, 2026
Metatranscriptomic Identification of Trubanaman Virus Sequences in Patient with Encephalitis, AustraliaKrispin Hajkowicz, John Woodford, Elango Subramonia Pillai, et al.
International Journal of Environmental Research and Public Health|January 24, 2020
Bacterial Profile, Multi-Drug Resistance and Seasonality Following Lower Limb Orthopaedic Surgery in Tropical and Subtropical Australian Hospitals: An Epidemiological Cohort StudyMark L Vickers, Emma L Ballard, Patrick N A Harris, et al.
Molecular Microbiology|February 10, 2021
Characterization of DtrJ as an IncC plasmid conjugative DNA transfer componentSteven J Hancock, Minh-Duy Phan, Leah W Roberts, et al.
Pageof 20